May 15, 2020

Tech Mahindra leverages Artificial Intelligence to Research on Potential Therapeutic Drugs for COVID-19

Conducts molecular docking studies of 19 FDA (Food and Drug Administration) approved ligands and anti-viral drugs

The story highlights the use Artificial Intelligence for researching COVID-19 treatment drugs at Tech Mahindra’s research and development arm ‘Makers Lab’. The story further elucidates the collaboration with a bio-scientist for plausible therapeutic drugs and research laboratories for synthesising and testing these compounds. Read More

Media Contact

Global Media Relations

Latest News